New generation of oral mucosal vaccines targeting dendritic cells

详细信息    查看全文

• 作者：Jennifer L Owen ; Bikash Sahay ; Mansour Mohamadzadeh
• 刊名：Current Opinion in Chemical Biology
• 出版年：December, 2013
• 年：2013
• 卷：17
• 期：6
• 页码：918-924
• 全文大小：1641 K

文摘

As most infectious organisms gain entry at mucosal surfaces, there is a great deal of interest in developing vaccines that elicit effective mucosal immune responses against pathogen challenge. Targeted vaccination is one of the most effective methods available to prevent and control infectious diseases. Mucosal vaccines can offer lower costs, better accessibility, needle free delivery, and a higher capacity for mass immunizations during pandemics. Both local mucosal immunity and robust systemic responses can be achieved through mucosal vaccination. Recent progress in understanding the molecular and cellular components of the mucosal immune system have allowed for the development of a novel mucosal vaccine platform utilizing specific dendritic cell-targeting peptides and orally administered lactobacilli to elicit efficient antigen specific immune responses against infections, including Bacillus anthracis in experimental models of disease.